Ito C, Onodera K, Watanabe T, Sato M
Department of Psychiatry, Tohoku University School of Medicine, Aobo-ku, Sendai, Japan.
Psychopharmacology (Berl). 1997 Apr;130(4):362-7. doi: 10.1007/s002130050251.
In this study, effects of histamine (HA) agents on methamphetamine (METH)-induced stereotyped behavior and behavioral sensitization were examined in rats. Pretreatment with a precursor of HA, L-histidine (750mg/kg), significantly inhibited the METH (3 mg/kg)-induced stereotyped behavior, whereas pretreatment with an inhibitor of HA synthesis, alpha-fluoromethylhistidine (FMH) (100 mg/kg), an H1 antagonist pyrilamine (5 mg/kg) or an H2 antagonist zolantidine (5 mg/kg) enhanced it. The inhibitory effect of L-histidine on METH-induced stereotyped behavior was significantly blocked by coadministration of pyrilamine and zolantidine, indicating that the effect is mediated through H1 and H2 receptors. Moreover, chronic treatment with METH (3 mg/kg) significantly enhanced stereotyped behavior at the rechallenge with METH (1 mg/kg). Chronic treatment with L-histidine (750 mg/kg) plus METH inhibited the METH-induced argumentation of stereotyped behavior, while that with FMH (100 mg/kg), pyrilamine (5 mg/kg) or zolantidine (5 mg/kg) potentiated it. These findings suggest that the HA neuron system has an inhibitory role in METH-induced stereotyped behavior and behavioral sensitization.
在本研究中,检测了组胺(HA)制剂对大鼠甲基苯丙胺(METH)诱导的刻板行为和行为敏化的影响。用HA的前体L-组氨酸(750mg/kg)预处理可显著抑制METH(3mg/kg)诱导的刻板行为,而用HA合成抑制剂α-氟甲基组氨酸(FMH)(100mg/kg)、H1拮抗剂吡苄明(5mg/kg)或H2拮抗剂佐兰替丁(5mg/kg)预处理则增强了该行为。吡苄明和佐兰替丁共同给药可显著阻断L-组氨酸对METH诱导的刻板行为的抑制作用,表明该作用是通过H1和H2受体介导的。此外,METH(3mg/kg)慢性处理可显著增强再次给予METH(1mg/kg)时的刻板行为。L-组氨酸(750mg/kg)加METH慢性处理可抑制METH诱导的刻板行为增强,而FMH(100mg/kg)、吡苄明(5mg/kg)或佐兰替丁(5mg/kg)慢性处理则增强了该行为。这些发现表明,HA神经元系统在METH诱导的刻板行为和行为敏化中具有抑制作用。